Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubhadeep Sinha

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutical Medicine|July 31, 2025
Developing Biosimilars: Challenges and OpportunitiesShubhadeep Sinha, Ruby Raphael
The Journal of the Association of Physicians of India|September 27, 2019
Efficacy, Safety and Immunogenecitystudy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Follicular Lymphoma Preliminary report (HERILY)Suresh Advani, Shubhadeep Sinha, Pankaj Thakur, et al.
The Journal of the Association of Physicians of India|July 24, 2019
A Prospective, Randomized, Multiple-Dose, Multi-Center, Comparative Clinical Study to Evaluate the Efficacy, Safety, Immunogenicity of a biosimilar Bevacizumab (Test product, Hetero) and Reference Medicinal Product (Bevacizumab, Roche) in Patients of Metastatic Colorectal CancerSuresh Advani, Ghanashyam Biswas, Shubhadeep Sinha, et al.
Cureus|September 13, 2021
A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive DisorderShubhadeep Sinha, Sreenivasa Chary, Pankaj Thakur, et al.
Cureus|October 25, 2021
Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical TrialShubhadeep Sinha, Sreenivasa Chary, Pankaj Thakur, et al.
The Journal of the Association of Physicians of India|February 2, 2021
Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in IndiaShubhadeep Sinha, Sreenivasa Chary, Mohan Reddy Bandi, et al.
Cureus|December 19, 2022
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in IndiaShubhadeep Sinha, Kumarasamy N, Vasanth Kumar Suram, et al.
BMC Rheumatology|June 11, 2020
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapyShubhadeep Sinha, Biswadip Ghosh, Syamasis Bandyopadhyay, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutical Medicine|July 31, 2025
Developing Biosimilars: Challenges and OpportunitiesShubhadeep Sinha, Ruby Raphael
The Journal of the Association of Physicians of India|September 27, 2019
Efficacy, Safety and Immunogenecitystudy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Follicular Lymphoma Preliminary report (HERILY)Suresh Advani, Shubhadeep Sinha, Pankaj Thakur, et al.
The Journal of the Association of Physicians of India|July 24, 2019
A Prospective, Randomized, Multiple-Dose, Multi-Center, Comparative Clinical Study to Evaluate the Efficacy, Safety, Immunogenicity of a biosimilar Bevacizumab (Test product, Hetero) and Reference Medicinal Product (Bevacizumab, Roche) in Patients of Metastatic Colorectal CancerSuresh Advani, Ghanashyam Biswas, Shubhadeep Sinha, et al.
Cureus|September 13, 2021
A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive DisorderShubhadeep Sinha, Sreenivasa Chary, Pankaj Thakur, et al.
Cureus|October 25, 2021
Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical TrialShubhadeep Sinha, Sreenivasa Chary, Pankaj Thakur, et al.
The Journal of the Association of Physicians of India|February 2, 2021
Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in IndiaShubhadeep Sinha, Sreenivasa Chary, Mohan Reddy Bandi, et al.
Cureus|December 19, 2022
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in IndiaShubhadeep Sinha, Kumarasamy N, Vasanth Kumar Suram, et al.
BMC Rheumatology|June 11, 2020
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapyShubhadeep Sinha, Biswadip Ghosh, Syamasis Bandyopadhyay, et al.
Pageof 1